Inomata Kei, Tsuji Kunikazu, Onuma Hiroaki, Hoshino Takashi, Udo Mio, Akiyama Masako, Nakagawa Yusuke, Katagiri Hiroki, Miyatake Kazumasa, Sekiya Ichiro, Muneta Takeshi, Koga Hideyuki
Department of Joint Surgery and Sports Medicine, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.
Department of Cartilage Regeneration, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.
BMC Musculoskelet Disord. 2019 Jan 5;20(1):8. doi: 10.1186/s12891-018-2391-1.
Osteoarthritis (OA) is a common joint disease in aging societies, which is accompanied by chronic inflammation and degeneration of the joint structure. Inflammation of the infrapatellar fat pad (IFP) and synovial membrane (IFP surface) plays essential roles in persistent pain development in patients with OA. To identify the point during the inflammatory process critical for persistent pain development, we performed a time course histological analysis in a rat arthritis model.
Wistar rats received single intra-articular injection of monoiodoacetic acid (MIA, 0.2 or 1.0 mg/30 μL) in the right knees or phosphate-buffered saline (PBS, 30 μL) as a control in the left knees. Pain avoidance behaviors (weight-bearing asymmetry and tactile hypersensitivity of the plantar surface of the hind paw) were evaluated on days 0, 1, 3, 5, 7, and 14 after injection. Histological assessments of the knee joint were performed on days 0, 1, 3, 5, and 7 after MIA injection.
Weight-bearing asymmetry was observed along with the onset of acute inflammation in both the low- (0.2 mg) and high-dose (1.0 mg) groups. In the low-dose group, weight-bearing asymmetry was completely reversed on day 10, indicating that joint pain seemed to alleviate between days 7 and 10. In contrast, we observed persistent joint pain after day 10 in the high-dose group. Histological assessments of the high-dose group indicated that the initial sign of inflammatory responses was observed in the perivascular region inside the IFP. Inflammatory cell infiltration from the perivascular region to the parenchymal region of the IFP was observed on day 3 and reached the IFP surface (synovial membrane) on day 7. Extensive fibrosis throughout the IFP was observed between days 5 and 7 after MIA injection.
Our data indicated that acute joint pain occurs along with the onset of acute inflammatory process. Irreversible structural changes in the IFP, such as extensive fibrosis, are observed prior to persistent pain development. Thus, we consider that this process may play important roles in persistent pain development.
骨关节炎(OA)是老龄化社会中一种常见的关节疾病,伴有慢性炎症和关节结构退变。髌下脂肪垫(IFP)和滑膜(IFP表面)的炎症在OA患者持续性疼痛的发生中起重要作用。为了确定炎症过程中对持续性疼痛发生至关重要的时间点,我们在大鼠关节炎模型中进行了时间进程组织学分析。
将Wistar大鼠右膝单次关节内注射单碘乙酸(MIA,0.2或1.0mg/30μL),左膝注射磷酸盐缓冲盐水(PBS,30μL)作为对照。在注射后第0、1、3、5、7和14天评估疼痛回避行为(负重不对称和后爪足底表面触觉超敏反应)。在MIA注射后第0、1、3、5和7天对膝关节进行组织学评估。
低剂量(0.2mg)和高剂量(1.0mg)组在急性炎症发作时均观察到负重不对称。在低剂量组中,负重不对称在第10天完全恢复,表明关节疼痛似乎在第7天至第10天之间有所缓解。相比之下,我们在高剂量组第10天后观察到持续性关节疼痛。高剂量组的组织学评估表明,在IFP内血管周围区域观察到炎症反应的初始迹象。在第3天观察到炎症细胞从血管周围区域浸润到IFP实质区域,并在第7天到达IFP表面(滑膜)。在MIA注射后第5天至第7天观察到整个IFP广泛纤维化。
我们的数据表明,急性关节疼痛与急性炎症过程的发作同时发生。在持续性疼痛发生之前,观察到IFP中不可逆的结构变化,如广泛纤维化。因此,我们认为这个过程可能在持续性疼痛的发生中起重要作用。